Kenvue Inc. (KVUE) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.
Total Assets Chart for Kenvue Inc.
Kenvue Inc. (KVUE) total assets for FY2025 were USD 27.1B, a 5.8% change from FY2024. Kenvue Inc.'s total assets grew from USD 29.2B in 2020 to USD 27.1B in 2025 (-7.2% over 5 years). Total assets compound annual growth rate: 5-year CAGR of -1.5%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $36.88B
- Implied Share Price
- $19.20
- Enterprise Value
- $44.38B
- Revenue (TTM)
- $15.41B
- EBITDA
- $3.48B
- Profit Margin
- 10.76%
- Trailing P/E
- 22.59
- Forward P/E
- 16.56
- Price/Book (MRQ)
- 3.49
- Price/Sales (TTM)
- 2.39
- EV/EBITDA
- 13.80
- EV/Revenue
- 2.88
- Dividend Yield
- 4.32%
- Book Value
- $5.50
- Free Cash Flow (FY2025)
- $1.72B
- Free Cash Flow Yield
- 4.67%
Snapshot as of 16th August 2026 — not point-in-time controlled, may lag the live market by a few days.